Protocol

mTOR

Volume 821 of the series Methods in Molecular Biology pp 295-303

Date:

Rapamycin-Induced Enhancement of Vaccine Efficacy in Mice

  • Chinnaswamy JagannathAffiliated withDepartment of Pathology and Laboratory Medicine, University of Texas Medical School Email author 
  • , Pearl BakhruAffiliated withDepartment of Pathology and Laboratory Medicine, University of Texas Medical School

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Th1 immunity protects against tuberculosis infection in mice and humans. The widely used BCG vaccine primes CD4 and CD8 T cells through signaling mechanisms from dendritic cells and macrophages. The latter express MHC-II and MHC-I molecules through which peptides from BCG vaccine are presented to CD4 and CD8 T cells, respectively. Since BCG sequesters within a phagosome that does not fuse with lysosomes, generation of peptides within antigen-presenting cells infected with BCG occurs with reduced efficiency. We demonstrate that activation of DCs containing BCG vaccine with rapamycin leads to an enhanced ability of DC vaccines to immunize mice against tuberculosis. Coadministration of rapamycin with BCG vaccine also enhanced Th1 immunity. We propose that rapamycin-mediated increase in Th1 responses offers novel models to study mTOR-mediated regulation of immunity.

Key words

Rapamycin Mycobacterium tuberculosis BCG vaccine Mouse mTOR CD4 CD8 T cells Th1 immunity